APP and Alzheimer disease: Based on this hypothesis and the discovery of familial AD mutations that facilitate Aβ production, transgenic mouse models overexpressing mutant APP and/or presenilins (PS), which form part of the γ-secretase complex, have been created to recapitulate AD pathology.